These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8534316)

  • 21. Investigation of the possible dopaminergic toxicity of 1-methyl-3-phenyl-1,2,3,6-tetrahydropyridine, an isomer to the neurotoxin MPTP.
    Nilsson K; Hallberg A; Pileblad E; Tunek A
    Pharmacol Toxicol; 1991 Jul; 69(1):38-42. PubMed ID: 1682909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of discrepancies in neurotoxic properties among 1-methyl-4-aryl-1,2,3,6-tetrahydropyridines.
    Bachurin SO; Sablin SO; Lermontova NN; Solyakov LS; Dubova LG; Tkachenko SE
    Mol Chem Neuropathol; 1992 Dec; 17(3):189-200. PubMed ID: 1362875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Dluzen D; Jain R; Liu B
    J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
    Fuller RW; Hemrick-Luecke SK
    J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxicity of an MPTP analogue, 2'CH3-MPTP, on monoaminergic systems in the mouse brain.
    Gupta M; Chen XL
    Ann N Y Acad Sci; 1992 May; 648():283-5. PubMed ID: 1353331
    [No Abstract]   [Full Text] [Related]  

  • 27. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.
    Donnan GA; Kaczmarczyk SJ; Solopotias T; Rowe P; Kalnins RM; Vajda FJ; Mendelsohn FA
    Clin Exp Neurol; 1986; 22():155-64. PubMed ID: 3495376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neurotoxicity of MPTP and its relationship to the pathophysiology of Parkinson's disease.
    Sandyk R; Iacono RP
    Int J Neurosci; 1989 Jan; 44(1-2):165-7. PubMed ID: 2485822
    [No Abstract]   [Full Text] [Related]  

  • 30. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
    Kita T; Saraya T; Konishi N; Matsunari Y; Shimada K; Nakamura M; O'Hara K; Wagner GC; Nakashima T
    Pharmacol Toxicol; 2003 Feb; 92(2):71-80. PubMed ID: 12747576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term manganese pretreatment partially protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Rojas P; Ríos C
    Neurochem Res; 1995 Oct; 20(10):1217-23. PubMed ID: 8746808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.
    Kuhlmann AC; Guilarte TR
    Toxicol Sci; 1999 Mar; 48(1):107-16. PubMed ID: 10330690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C; Marien M
    Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM; Murphy DL
    J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metallothionein inducers protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice.
    Rojas P; Ríos C
    Neurochem Res; 1997 Jan; 22(1):17-22. PubMed ID: 9021756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lau YS; Trobough KL; Crampton JM; Wilson JA
    Gen Pharmacol; 1990; 21(2):181-7. PubMed ID: 2332138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration.
    Lange KW
    Eur J Pharmacol; 1990 Jan; 175(1):57-61. PubMed ID: 2323346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys.
    Jan C; Pessiglione M; Tremblay L; Tandé D; Hirsch EC; François C
    Eur J Neurosci; 2003 Oct; 18(7):2082-6. PubMed ID: 14622241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel free radical spin traps protect against malonate and MPTP neurotoxicity.
    Matthews RT; Klivenyi P; Mueller G; Yang L; Wermer M; Thomas CE; Beal MF
    Exp Neurol; 1999 May; 157(1):120-6. PubMed ID: 10222114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.